Perfusion MR Imaging in Gliomas: Comparison with Histologic Tumor Grade

Korean Journal of Radiology

Volumn 2, Issue 1, 2001, Pages 1-7

  Lee, Sun Joo ^a   Kim, Jae Hyoung ^a,b,c   Kim, Young Mee ^a   Lee, Gyung Kyu ^a   Lee, Eun Ja ^a   Park, In Sung ^a,c   Jung, Jin Myung ^a,c   Kang, Kyeong Hun ^b   Shin, Taemin ^b  

^a Gyeongsang National University School of Medicine   (South Korea)

^b Gyeongsang National University   (South Korea)

^c Gyeongsang Inst for Neuroscience   (South Korea)

Author keywords

Blood flow cerebral blood vessels; Brain neoplasms; Contrast enhancement; Flow dynamics magnetic resonance (MR); MR brain

Indexed keywords

CONTRAST MEDIUM; DIAGNOSTIC AGENT; GADODIAMIDE; GADOLINIUM PENTETATE;

ADULT; ARTICLE; ASTROCYTOMA; BRAIN; BRAIN CIRCULATION; BRAIN TUMOR; FEMALE; GLIOBLASTOMA; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY;

ADULT; ASTROCYTOMA; BRAIN; BRAIN NEOPLASMS; CEREBROVASCULAR CIRCULATION; CONTRAST MEDIA; FEMALE; GADOLINIUM DTPA; GLIOBLASTOMA; HUMAN; MAGNETIC RESONANCE IMAGING; MALE; SUPPORT, NON-U.S. GOV'T;

EID: 0035238615     PISSN: 12296929     EISSN: None     Source Type: Journal    
DOI: 10.3348/kjr.2001.2.1.1     Document Type: Article

References (27)

1. Russell D, Rubinstein L. Tumours of central neuroepithelial origin. In Rubinstein LJ, ed. Pathology of tumours of the central nervous system. Baltimore, Md.: Williams & Wilkins, 1989;83-350
2. Van Kirk OC, Cornell SH, Jacoby CG. Posterior fossa intraaxial tumors: a comparision of computed tomography with other imaging methods. J Comput Assist Tomogr 1979;3:31-39
3. Joyce P, Bentson J, Takahashi M, Winter J, Wilson G, Byrd S. The accuracy of predicting histologic grades of supratentorial astrocytomas on the basis of computerized tomography and cerebral angiography. Neuroradiology 1978;16:346-348
4. Seeger JF, Burke DP, Knake JE, Gabrielsen TO. Computed tomographic and angiographic evaluation of hemangioblastoma. Radiology 1981;138:65-73
5. Aronen HJ, Gazit IE, Louis DN, et al. Cerebral blood volume maps of gliomas: comparision with tumor grade and histologic findings. Radiology 1994;191:41-51
6. Edelman RR, Mattle HP, Atkinson DJ, et al. Cerebral blood flow: assessment with dynamic contrast-enhanced T2*-weighted MR imaging at 1.5T. Radiology 1990;176:211-220
7. Rosen BR, Belliveau JW, Aronen HJ, et al. Susceptibility contrast imaging of cerebral blood volume: human experience. Magn Reson Med 1991;22:293-299
8. Aronen HJ, Cohen MS, Belliveau JW, Fordham JA, Rosen BR. Ultrafast imaging of brain tumors. Top Magn Reson Imaging 1993;5:14-24
9. Le Bihan D, Douek P, Argyropoulou M, Turner R, Patronas N, Fulham M. Diffusion and perfusion magnetic resonance imaging in brain tumors. Top Magn Reson Imaging 1993;5:25-31
10. Maeda M, Itoh S, Kimura H, et al. Tumor vascularity in the brain: evaluation with dynamic susceptibility-contrast MR imaging. Radiology 1993;189:233-238
11. Maeda M, Itoh S, Kimura H, et al. Vascularity of meningioma and neuroma: assessment with dynamic susceptibility-contrast MR imaging. AJR 1994;163:181-186
12. Kim JS, Lee GK, Kim JH, et al. Blood volume of intraaxial brain tumor: evaluation with dynamic contrast-enhanced T2*-weighted MR imaging. J Korean Radiol Soc 1997;37:783-788
13. Kim HD, Chang KH, Song IC, et al. Perfusion MR imaging of the brain tumor: preliminary report. J Korean Soc Magn Reson Med 1997;1:119-124
14. Choi JY, Sun JS, Kim SY, et al. Effect of steroid on brain tumors and surround edemas: observation with regional cerebral blood volume (rCBV) maps of perfusion MRI. J Korean Radiol Soc 2000;42:15-21
15. Sugahara T, Korogi Y, Kochi M, et al. Correlation of MR imaging-determined cerebral blood volume maps with histologic and angiographic determination of vascularity of gliomas. AJR 1998;171:1479-1486
16. Knopp EA, Cha S, Johnson G, et al. Glial neoplasms: dynamic contrast-enhanced T2*-weighted MR imaging. Radiology 1999;211:791-798
17. Kleihues P, Burger PC, Scheithauer BW. Histologic typing of tumours of the central nervous system. 2nd ed. Berlin, Germany: Springer-Verlag, 1993;11-30
18. Thompson HK, Starmer CF, Whalen RE, McIntosh HD. Indicator transit time considered as a gamma variate. Circ Res 1964;14:502-515
19. Benner T, Heiland S, Erb G, Forsting M, Sartor K. Accuracy of gamma-variate fits to concentration-time curves from dynamic susceptibility-contrast MRI: influence of time resolution, maximal signal drop and signal-to-noise. Magn Reson Imaging 1997;15:307-317
20. Rosen BR, Belliveau JW, Vevea JM, et al. Perfusion MR imaging with NMR contrast agents. Magn Reson Med 1990;14:249-265
21. Brem S, Cotran R, Folkman J. Tumor angiogenesis: a quantitative method for histologic grading. J Natl Cancer Inst 1972;48: 347-356
22. Edelman RR, Siewert B, Darby DG, et al. Quantitative mapping of cerebral blood flow and functional localization with echo-planar MR imaging and signal targeting with alternating radiofrequency. Radiology 1994;192:513-520
23. Belliveau JW, Rosen BR, Kantor HL, et al. Functional cerebral imaging by susceptibility contrast NMR. Magn Reson Med 1990;14:538-546
24. Gückel F, Brix G, Rempp K, Deimling M, Rother J, Georgi M. Assessment of cerebral blood volume with dynamic susceptibility contrast enhanced gradient echo imaging. J Comput Assist Tomogr 1994;18:344-351
25. Wenz F, Rempp K, Hess T, et al. Effect of radiation on blood volume in low-grade astrocytomas and normal brain tissue: quantification with dynamic susceptibility contrast MR imaging. AJR 1996;166:187-193
26. Cha S, Knopp EA, Johnson G, et al. Dynamic contrast-enhanced T2*-weighted MR imaging of recurrent malignant gliomas treated with thalidomide and carboplatin. AJNR 2000;21:881-890
27. Sugahara T, Korogi Y, Tomiguchi S, et al. Posttherapeutic intraaxial brain tumor: the value of perfusion-sensitive contrastenhanced MR imaging for differentiating tumor recurrence from nonneoplastic contrast-enhancing tissue. AJNR 2000;21:901-909